96 related articles for article (PubMed ID: 1325109)
1. Phase II study of cisplatin continuous infusion plus vindesine in the treatment of non-small-cell lung cancer.
Mori K; Saito Y; Tominaga K
Am J Clin Oncol; 1992 Aug; 15(4):344-7. PubMed ID: 1325109
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer.
Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N
Cancer Chemother Pharmacol; 1992; 31(2):81-4. PubMed ID: 1280537
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer.
Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N
Cancer Chemother Pharmacol; 1990; 26(6):389-92. PubMed ID: 2171793
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.
Nakanishi Y; Takayama K; Kawasaki M; Yatsunami J; Inutsuka S; Wakamatsu K; Tsuruta N; Hara N
Am J Clin Oncol; 1997 Aug; 20(4):393-7. PubMed ID: 9256897
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
6. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.
Fukuoka M; Negoro S; Masuda N; Kusunoki Y; Matsui K; Ryu S; Takifuji N; Kudoh S; Takada M
Am J Clin Oncol; 1992 Feb; 15(1):18-22. PubMed ID: 1312768
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer.
Saito H; Shimokata K; Saka H; Yamamoto M; Ogasawara T; Nomura F; Sakai S; Iwata M; Murate T; Miyachi T
Cancer Chemother Pharmacol; 1993; 33(2):154-6. PubMed ID: 8261575
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
Furuse K; Kubota K; Kawahara M; Kodama N; Ogawara M; Akira M; Nakajima S; Takada M; Kusunoki Y; Negoro S
J Clin Oncol; 1995 Apr; 13(4):869-75. PubMed ID: 7707113
[TBL] [Abstract][Full Text] [Related]
10. A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Klastersky J; Sculier JP; Ries F; Dabouis G; Libert P; Schmerber J; Thiriaux J; Berchier MC; Bureau G; Van Cutsem O
Lung Cancer; 1994 Dec; 11(5-6):373-84. PubMed ID: 7704494
[TBL] [Abstract][Full Text] [Related]
11. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
Masuda N
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
[TBL] [Abstract][Full Text] [Related]
12. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
Itami S; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N; Nakagawa K
Gan To Kagaku Ryoho; 1990 May; 17(5):1015-20. PubMed ID: 2159265
[TBL] [Abstract][Full Text] [Related]
13. A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
Shinkai T; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Kojima A; Oshita F; Saijo N
Eur J Cancer; 1991; 27(5):571-5. PubMed ID: 1647183
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
Shimizu E; Ogura T; Sone S; Nakayama T; Doi H; Takishita Y; Bando H; Kobayashi M; Kimura K; Sasaki H
Oncology; 1993; 50(1):5-9. PubMed ID: 8380634
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Hayashi Y; Kato M; Matsuura T; Yamada Y; Adachi S; Ito G; Yamamoto K; Takeuchi T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
[TBL] [Abstract][Full Text] [Related]
16. Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).
Riggi M; Ruffie P; Voisin S; Monnet I; de Cremoux H; Saltiel JC; Martin M; Vergne L; Huet J; Cvitkovic E
Eur J Cancer; 1991; 27(10):1238-42. PubMed ID: 1659842
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tominaga K; Sakurai M; Suga J; Miyaoka H; Sano T; Keicho N
Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
[TBL] [Abstract][Full Text] [Related]
18. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
Nakano T; Ikegami H; Nakamura S; Kawase T; Nishikawa H; Yokota S; Yoshida M; Tachibana T; Igarashi T; Komuta K; Higashino K
Br J Cancer; 1996 May; 73(9):1096-100. PubMed ID: 8624270
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
Tejedor M; Valerdi JJ; López R; Domínguez MA; Arias F; Illarramendi JJ; Martínez E
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):813-8. PubMed ID: 7860393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
